The Link Between Inflammation and Cancer : Wounds that do not heal

The transcription factor NF-kB has long been known to play a central role in the immune system by regulating the expression of key genes. Moreover, activation of this transcription factor helps a wide variety of cell types survive damage induced by pro-apoptotic stimuli. Owing to its critical role i...

Full description

Corporate Author: SpringerLink (Online service)
Other Authors: Dalgleish, Angus G. (Editor), Haefner, Burkhard (Editor)
Format: eBook
Language:English
Published: New York, NY Springer US 2006, 2006
Edition:1st ed. 2006
Series:Cancer Treatment and Research
Subjects:
Online Access:
Collection: Springer eBooks 2005- - Collection details see MPG.ReNa
LEADER 02849nmm a2200349 u 4500
001 EB000354189
003 EBX01000000000000000207241
005 00000000000000.0
007 cr|||||||||||||||||||||
008 130626 ||| eng
020 |a 9780387262833 
100 1 |a Dalgleish, Angus G.  |e [editor] 
245 0 0 |a The Link Between Inflammation and Cancer  |h Elektronische Ressource  |b Wounds that do not heal  |c edited by Angus G. Dalgleish, Burkhard Haefner 
250 |a 1st ed. 2006 
260 |a New York, NY  |b Springer US  |c 2006, 2006 
300 |a XII, 254 p  |b online resource 
505 0 |a Inflammation and Cancer -- Chronic Inflammation and Pathogenesis of GI and Pancreatic Cancers -- Cytokines, NF-?B, Microenvironment, Intestinal Inflammation and Cancer -- Regulation if NF-?B Transcriptional Activity -- The Role of Immune Cells in the Tumor Microenvironment -- Tumor-Microenvironment Interactions -- CD95L/FasL and TRAIL in Tumour Surveillance and Cancer Therapy -- Infection & Neoplastic Growth 101 -- Cytokines as Mediators and Targets for Cancer Cachexia -- Targeting NF-?B in Anticancer Adjunctive Chemotherapy 
653 |a Cancer research 
653 |a Oncology   
653 |a Oncology 
653 |a Cancer Research 
653 |a Laboratory Medicine 
653 |a Laboratory medicine 
700 1 |a Haefner, Burkhard  |e [editor] 
710 2 |a SpringerLink (Online service) 
041 0 7 |a eng  |2 ISO 639-2 
989 |b Springer  |a Springer eBooks 2005- 
490 0 |a Cancer Treatment and Research 
856 |u https://doi.org/10.1007/b137303?nosfx=y  |x Verlag  |3 Volltext 
082 0 |a 616.994 
520 |a The transcription factor NF-kB has long been known to play a central role in the immune system by regulating the expression of key genes. Moreover, activation of this transcription factor helps a wide variety of cell types survive damage induced by pro-apoptotic stimuli. Owing to its critical role in the regulation of pro-inflammatory genes, NF-kB has long been regarded as a promising target for the discovery of anti-inflammatory drugs. More recently, NF-kB has emerged as a major culprit in a variety of human cancers mainly due to its ability to protect transformed cells from apoptosis. This finding should not have come as a surprise since there exists a link between inflammation and many types of cancer which was already suggested by Galen and later demonstrated by Virchow. This link, of crucial importance for the design of novel strategies for cancer treatment, is the topic of this book. Series Editor Cover Comments: "Inflammation is a known risk factor for a number of cancers. In this text, experts discuss the pathophysiology and molecular alterations that link these two processes. Potential therapeutics and preventive strategies are discussed." Steven T. Rosen, M.D. Series Editor